AGT and cardiac hypertrophy: Nonetheless, while the in vitro comparative studies suggest a potentially specific protective effect of ECSIT‐X4 against Ang II‐induced cardiomyocyte hypertrophy, a limitation remains in the lack of additional in vivo validation to definitively establish its targeted protective role in pressure overload‐induced cardiac hypertrophy in this study.